A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D759 and D150 (CKD-393)
NCT04431687
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG:
CKD 501
DRUG:
D759, D150
DRUG:
CKD-501, D759, D150
Sponsor
Chong Kun Dang Pharmaceutical